+27 (0)83 440 0793 mark.fyvie@vxpharma.com
Select Page

TRIAL SITES

150 clinical studies across a wide range of major chronic disease areas

PRIMARY TRIAL SITE

The nerve centre of VX Pharma is in Gauteng, an economically active metropolis spanning the cities of Johannesburg and Pretoria. The 10-million strong community of Gauteng comprises 20% of South Africa’s population and is responsible for a third of the country’s GDP. 

SYZYGY CLINICAL RESEARCH SERVICES

Our phase III and IV outpatient trial business in Pretoria, Syzygy, gives VX Pharma late-phase capabilities as well as unprecedented access to outpatients for inpatient studies through their exclusive strategic alliance with the company’s founders: The Intercare Group.

The Intercare Group operates 15 medical and dental centres around the country, managing the healthcare needs of over 600 000 patients per annum. The group also has two sub-acute hospitals and two day hospitals, where specialists and doctors conduct the following types of day surgery: dental surgery, dermatology, ENT, gastroenterology, general surgery, gynaecology, maxillo-facial surgery, ophthalmology, orthopaedic surgery, periodontics, plastic surgery and urology.

CURRENT TRIALS OPEN TO ENROLLMENT

  • Insulin Dependent Type 2 Diabetes Mellitus in Elderly
  • Type 2 Diabetes Mellitus and Established Vascular Disease
  • Type 2 Diabetes Mellitus at high vascular risk
  • Mild to Moderate Asthma in Adults
  • Insulin Dependent Type 2 Diabetes Mellitus in Adults
  • New Therapy in Treatment Naive HIV Positive Adults
  • Chronic Obstructive Pulmonary Disease (COPD): Severe to Very Severe COPD Patients
  • Type I Diabetes Mellitus
  • Moderate to Severe Uncontrolled Asthma in Adolescents and Adults
  • Uncomplicated Influenza (Phase I and Phase III)

AFFILIATES & ALLIANCES

CONTACT US

Need more information? Send us an enquiry.

I am interested in...
My interest is as a...